Results
|
881.
|
|
|
882.
|
|
|
883.
|
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors. [electronic resource] by
- de Moel, Emma C
- Rozeman, Elisa A
- Kapiteijn, Ellen H
- Verdegaal, Els M E
- Grummels, Annette
- Bakker, Jaap A
- Huizinga, Tom W J
- Haanen, John B
- Toes, René E M
- van der Woude, Diane
Producer: 20200304
In:
Cancer immunology research vol. 7
Availability: No items available.
|
|
884.
|
|
|
885.
|
Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab. [electronic resource] by
- Lin, Andrew L
- Jonsson, Philip
- Tabar, Viviane
- Yang, T Jonathan
- Cuaron, John
- Beal, Katherine
- Cohen, Marc
- Postow, Michael
- Rosenblum, Marc
- Shia, Jinru
- DeAngelis, Lisa M
- Taylor, Barry S
- Young, Robert J
- Geer, Eliza B
Producer: 20190528
In:
The Journal of clinical endocrinology and metabolism vol. 103
Availability: No items available.
|
|
886.
|
|
|
887.
|
|
|
888.
|
|
|
889.
|
|
|
890.
|
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada. [electronic resource] by
- Dai, Wei Fang
- Beca, Jaclyn M
- Croxford, Ruth
- Isaranawatchai, Wanrudee
- Menjak, Ines B
- Petrella, Teresa M
- Mittmann, Nicole
- Earle, Craig C
- Gavura, Scott
- Hanna, Timothy P
- Chan, Kelvin K W
Producer: 20201218
In:
BMC cancer vol. 20
Availability: No items available.
|
|
891.
|
|
|
892.
|
|
|
893.
|
|
|
894.
|
|
|
895.
|
|
|
896.
|
|
|
897.
|
Safety of shortened infusion times for combined ipilimumab and nivolumab. [electronic resource] by
- Gassenmaier, Maximilian
- Lipp, Hans-Peter
- Scheu, Alexander
- Wagner, Nikolaus Benjamin
- Kofler, Lukas
- Mueller, Alisa
- Doecker, Dennis
- Eigentler, Thomas Kurt
- Garbe, Claus
- Forschner, Andrea
Producer: 20181120
In:
Cancer immunology, immunotherapy : CII vol. 67
Availability: No items available.
|
|
898.
|
|
|
899.
|
|
|
900.
|
|